170 related articles for article (PubMed ID: 11964051)
1. Establishment of a transplantable tumor line (IP) derived from rat pulmonary carcinoma, developing humoral hypercalcemia of malignancy in IP-bearing rats.
Nakanishi M; Yamate J; Nakatsuji S; Ide M; Sawamoto O; Kuwamura M; Kotani T; Sakuma S
Virchows Arch; 2002 Feb; 440(2):195-204. PubMed ID: 11964051
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a transplantable rat pulmonary carcinoma-derived cell line (IP-B12) as a new model of humoral hypercalcemia of malignancy and bone metastasis.
Nakanishi M; Ide M; Kawashima M; Kuwamura M; Kumagai D; Sawamoto O; Yamate J
Tumour Biol; 2003; 24(2):70-6. PubMed ID: 12853701
[TBL] [Abstract][Full Text] [Related]
3. Humoral hypercalcemia of malignancy in female F344 rats implanted with a transplantable rat pulmonary carcinoma line (IP).
Nakanish IM; Yamate J; Ide M; Sawamoto O; Kuwamur M; Kotani T; Nakatsuji S
J Vet Med Sci; 2001 Oct; 63(10):1135-8. PubMed ID: 11714032
[TBL] [Abstract][Full Text] [Related]
4. Morphological changes in the parathyroid gland of rats with humoral hypercalcaemia of malignancy.
Nakanishi M; Sawamoto O; Kawashima M; Kuwamura M; Yamate J
J Comp Pathol; 2004 Jul; 131(1):92-7. PubMed ID: 15144804
[TBL] [Abstract][Full Text] [Related]
5. Dependence of humoral hypercalcemia of malignancy on parathyroid hormone-related protein expression in the canine anal sac apocrine gland adenocarcinoma (CAC-8) nude mouse model.
Gröne A; Weckmann MT; Blomme EA; Capen CC; Rosol TJ
Vet Pathol; 1998 Sep; 35(5):344-51. PubMed ID: 9754539
[TBL] [Abstract][Full Text] [Related]
6. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
7. Humoral hypercalcemia of malignancy: severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression.
Richard V; Lairmore MD; Green PL; Feuer G; Erbe RS; Albrecht B; D'Souza C; Keller ET; Dai J; Rosol TJ
Am J Pathol; 2001 Jun; 158(6):2219-28. PubMed ID: 11395400
[TBL] [Abstract][Full Text] [Related]
8. Measurement of circulating parathyroid hormone-related protein in rats with humoral hypercalcemia of malignancy using a two-site immunoradiometric assay.
Gaich G; Burtis WJ
Endocrinology; 1990 Sep; 127(3):1444-9. PubMed ID: 2387260
[TBL] [Abstract][Full Text] [Related]
9. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
Sato K; Onuma E; Yocum RC; Ogata E
Semin Oncol; 2003 Oct; 30(5 Suppl 16):167-73. PubMed ID: 14613038
[TBL] [Abstract][Full Text] [Related]
10. In vivo evidence for progressive activation of parathyroid hormone-related peptide gene transcription with tumor growth and stimulation of osteoblastic bone formation at an early stage of humoral hypercalcemia of cancer.
Yamato H; Nagai Y; Inoue D; Ohnishi Y; Ueyama Y; Ohno H; Matsumoto T; Ogata E; Ikeda K
J Bone Miner Res; 1995 Jan; 10(1):36-44. PubMed ID: 7747629
[TBL] [Abstract][Full Text] [Related]
11. Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat model.
Schilling T; Blind E; Baier R; Sinn HP; Moallem E; Silver J; Ziegler R; Raue F
J Bone Miner Res; 1995 Jan; 10(1):7-16. PubMed ID: 7747633
[TBL] [Abstract][Full Text] [Related]
12. Histopathological study of time course changes in PTHrP-induced incisor lesions of rats.
Kato A; Suzuki M; Karasawa Y; Sugimoto T; Doi K
Toxicol Pathol; 2005; 33(2):230-8. PubMed ID: 15902966
[TBL] [Abstract][Full Text] [Related]
13. Extracellular calcium-sensing receptor (CaR) expression and its potential role in parathyroid hormone-related peptide (PTHrP) secretion in the H-500 rat Leydig cell model of humoral hypercalcemia of malignancy.
Sanders JL; Chattopadhyay N; Kifor O; Yamaguchi T; Brown EM
Biochem Biophys Res Commun; 2000 Mar; 269(2):427-32. PubMed ID: 10708570
[TBL] [Abstract][Full Text] [Related]
14. Conflicting actions of parathyroid hormone-related protein and serum calcium as regulators of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase expression in a nude rat model of humoral hypercalcemia of malignancy.
Michigami T; Yamato H; Suzuki H; Nagai-Itagaki Y; Sato K; Ozono K
J Endocrinol; 2001 Nov; 171(2):249-57. PubMed ID: 11691644
[TBL] [Abstract][Full Text] [Related]
15. Tumor resection and antibodies to parathyroid hormone-related protein cause similar changes on bone histomorphometry in hypercalcemia of cancer.
Kukreja SC; Rosol TJ; Wimbiscus SA; Shevrin DH; Grill V; Barengolts EI; Martin TJ
Endocrinology; 1990 Jul; 127(1):305-10. PubMed ID: 2361475
[TBL] [Abstract][Full Text] [Related]
16. Malignant hypercalcemia in vulvar cancer.
Bilenchi R; Poggiali S; Pisani C; Santopietro R; Miracco C; Vatti R; Lucani B; Andreassi A; Gonnelli S
Minerva Ginecol; 2005 Oct; 57(5):569-74. PubMed ID: 16205603
[TBL] [Abstract][Full Text] [Related]
17. PTHrP and PTH/PTHrP receptor 1 expression in odontogenic cells of normal and HHM model rat incisors.
Kato A; Suzuki M; Karasawa Y; Sugimoto T; Doi K
Toxicol Pathol; 2005; 33(4):456-64. PubMed ID: 16036863
[TBL] [Abstract][Full Text] [Related]
18. Humoral hypercalcemia of malignancy: some enigmas on the clinical features.
Ikeda K; Ogata E
J Cell Biochem; 1995 Mar; 57(3):384-91. PubMed ID: 7768974
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone-related protein in tumor tissues obtained from patients with humoral hypercalcemia of malignancy.
Tsuchihashi T; Yamaguchi K; Miyake Y; Otsubo K; Nagasaki K; Honda S; Akiyama Y; Maeda Y; Koike M; Alper O
J Natl Cancer Inst; 1990 Jan; 82(1):40-4. PubMed ID: 2293655
[TBL] [Abstract][Full Text] [Related]
20. Incidence of humoral hypercalcemia of malignancy among hypercalcemic patients with cancer.
Szymanski JJ; Otrock ZK; Patel KK; Scott MG
Clin Chim Acta; 2016 Jan; 453():190-3. PubMed ID: 26706788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
